Browsing: HoneyNaps

BOSTON, Aug. 28, 2026 /PRNewswire/ — As sleep health increasingly emerges as an important factor in the prevention and management of cardiovascular disease, the medical community is paying greater attention to the relationship between sleep disorders and cardiovascular conditions

HoneyNaps wins FDA clearance for AI sleep analysis device July 17, 2026 | 10:31(0) user say HoneyNaps received US FDA 510(k) clearance, designated K253390, for SOMNUM V3.0, validating AI-based classification of sleep-disordered breathing subtypes and supporting next-generation digital biomarker development.